Grupa HASCO

hasco-lek.pl

Hasco-Lek SA is a leading manufacturer of medicines, dietary supplements and medical products manufactured in two modern factories in the capital of Lower Silesia and in the suburbs of Siechnice. PPF Hasco-Lek SA has been operating on the Polish market since 1984, combining over 30 years of experience with state-of-the-art technology.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharmacy Market

GLUCARE.HEALTH PARTNERS WITH NOVO NORDISK FOR INNOVATIVE WEIGHT MANAGEMENT PATIENT PROGRAM

Glucare.Health and NovoNordisk: | June 09, 2022

news image

GluCare.Health, one of the Middle East's leading health tech startups, has partnered with global pharmaceutical company Novo Nordisk, market leader in Diabetes & Obesity, to introduce a blueprint for the future of healthcare. The partnership will see a 150-patient weight management pilot program that will combine new digital bio-markers, using wearable technology and devices for continuous data monitoring, with existing therapeutics. It introduces the Middle East's fir...

Read More

Business Insights

ASYMCHEM ACQUIRES SNAPDRAGON CHEMISTRY

Asymchem | February 14, 2022

news image

Asymchem Laboratories Co., Ltd. a leading CDMO serving the global pharmaceutical and biotech industry, today announced its agreement to acquire Snapdragon Chemistry, Inc., a US-based chemical technology company providing industry-leading expertise in continuous manufacturing and early-stage chemical process development services to the pharmaceutical and fine chemical industries for US $57.94 million. This addition will significantly expand Asymchem's footprint in the US, offering customers a...

Read More

Business Insights

ORSINI SPECIALTY PHARMACY SELECTED BY SANOFI AS A LIMITED DISTRIBUTION PARTNER FOR NEXVIAZYME®

Orsini Specialty Pharmacy | September 28, 2021

news image

Orsini Specialty Pharmacy, the leading independent specialty pharmacy focused on rare diseases and gene therapies, announced that Sanofi has selected it as a limited distribution partner for Nexviazyme® (avalglucosidase alfa-ngpt). Nexviazyme, an enzyme replacement therapy (ERT), is used for treating patients one year of age and older with late-onset Pompe disease (lysosomal acid alpha-glucosidase [GAA] deficiency). This progressive and debilitating muscle disorder impairs a person's abi...

Read More

Research, Business Insights

ALLUCENT EXTENDS MEDIDATA CLINICAL CLOUD USAGE TO EXPEDITE NEW DRUG DEVELOPMENT

Medidata Solutions | March 13, 2023

news image

Medidata, a leading provider of innovative software solutions for clinical trials that streamline the clinical trial process, reduce time and cost, and accelerate the development of new treatments, recently announced that Allucent, a contract research organization (CRO) that brings innovation to biopharma firms, is expanding the global use of Medidata's Clinical Cloud to enhance its clinical trial operations offering. This agreement extends Allucent's current usage of Me...

Read More
news image

Pharmacy Market

GLUCARE.HEALTH PARTNERS WITH NOVO NORDISK FOR INNOVATIVE WEIGHT MANAGEMENT PATIENT PROGRAM

Glucare.Health and NovoNordisk: | June 09, 2022

GluCare.Health, one of the Middle East's leading health tech startups, has partnered with global pharmaceutical company Novo Nordisk, market leader in Diabetes & Obesity, to introduce a blueprint for the future of healthcare. The partnership will see a 150-patient weight management pilot program that will combine new digital bio-markers, using wearable technology and devices for continuous data monitoring, with existing therapeutics. It introduces the Middle East's fir...

Read More
news image

Business Insights

ASYMCHEM ACQUIRES SNAPDRAGON CHEMISTRY

Asymchem | February 14, 2022

Asymchem Laboratories Co., Ltd. a leading CDMO serving the global pharmaceutical and biotech industry, today announced its agreement to acquire Snapdragon Chemistry, Inc., a US-based chemical technology company providing industry-leading expertise in continuous manufacturing and early-stage chemical process development services to the pharmaceutical and fine chemical industries for US $57.94 million. This addition will significantly expand Asymchem's footprint in the US, offering customers a...

Read More
news image

Business Insights

ORSINI SPECIALTY PHARMACY SELECTED BY SANOFI AS A LIMITED DISTRIBUTION PARTNER FOR NEXVIAZYME®

Orsini Specialty Pharmacy | September 28, 2021

Orsini Specialty Pharmacy, the leading independent specialty pharmacy focused on rare diseases and gene therapies, announced that Sanofi has selected it as a limited distribution partner for Nexviazyme® (avalglucosidase alfa-ngpt). Nexviazyme, an enzyme replacement therapy (ERT), is used for treating patients one year of age and older with late-onset Pompe disease (lysosomal acid alpha-glucosidase [GAA] deficiency). This progressive and debilitating muscle disorder impairs a person's abi...

Read More
news image

Research, Business Insights

ALLUCENT EXTENDS MEDIDATA CLINICAL CLOUD USAGE TO EXPEDITE NEW DRUG DEVELOPMENT

Medidata Solutions | March 13, 2023

Medidata, a leading provider of innovative software solutions for clinical trials that streamline the clinical trial process, reduce time and cost, and accelerate the development of new treatments, recently announced that Allucent, a contract research organization (CRO) that brings innovation to biopharma firms, is expanding the global use of Medidata's Clinical Cloud to enhance its clinical trial operations offering. This agreement extends Allucent's current usage of Me...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us